Opinion|Videos|January 7, 2025

When to Consider Systemic Treatment for Prurigo Nodularis Patients

TJ Chao, MPAS, PA-C, discusses how systemic treatments for prurigo nodularis are considered for patients with moderate to severe disease, highlighting key patient-specific factors such as comorbidities and disease severity when initiating treatment.

Video content above is prompted by the following:

For which type of patient would you consider systemic treatments for prurigo nodularis patients?

What patient-specific factors do you consider when starting treatment?

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME